L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Clinical trial NCT07227350 · RECRUITING

Trial details

NCT number: NCT07227350
Sponsor: Philogen S.p.A.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Basal Cell Carcinoma

Start date: 2026-06-01
Primary completion: 2031-02-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.